38822-56-9

Basic information

• Product Name: 6-AMINO-N-BETA-D-GALACTOPYRANOSYL HEXANAMIDE
• Synonyms: 6-AMINO-N-BETA-D-GALACTOPYRANOSYL HEXANAMIDE;N-(E-AMINOCAPROYL)-B-D-GALACTOPYRANOSYLAMINE;N-(E-AMINOCAPROYL)-BETA-D-GALACTOPYRANOSYLAMINE;N-epsilon-aminocaproyl-B-D-*galactopyranosylamine;6-Amino-N-b-D-galactopyranosyl Hexanamide;N-(GAMMA-AMINOCAPROYL)-BETA-D-GALACTOPYRANOSYLAMINE;N-(e-Aminocaproyl)--D-galactopyranosylamine;N-(epsilon-aminocaproyl)-beta-D-galactopyranosylamine
• CAS NO: 38822-56-9
• Molecular Formula: C₁₂H₂₄N₂O₆
• Molecular Weight: 292.33
• Product Categories: Affinity Chromatography;Carbohydrates & Derivatives;Amines
• Mol File: 38822-56-9.mol

Chemical Properties

• Melting Point: 206-208°C
• Appearance: /
• Storage Temp.: -20°C Freezer
• Solubility: DMSO (Slightly, Heated), Water (Slightly)
• CAS DataBase Reference: 6-AMINO-N-BETA-D-GALACTOPYRANOSYL HEXANAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-AMINO-N-BETA-D-GALACTOPYRANOSYL HEXANAMIDE(38822-56-9)
• EPA Substance Registry System: 6-AMINO-N-BETA-D-GALACTOPYRANOSYL HEXANAMIDE(38822-56-9)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 38822-56-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
6-AMINO-N-BETA-D-GALACTOPYRANOSYL HEXANAMIDE is used as a key compound for the preparation of sugar-specific antibodies using liposomes. This application is significant because it allows for the development of targeted therapies and diagnostic tools that can specifically recognize and interact with certain sugar molecules, which are often involved in various diseases and biological processes.
Used in Immunology Research:
In the field of immunology, 6-AMINO-N-BETA-D-GALACTOPYRANOSYL HEXANAMIDE plays a crucial role in the study of sugar-protein interactions and the development of antibodies that can specifically recognize and bind to certain sugar structures. This can lead to a better understanding of the immune system and the development of novel therapeutic strategies for various diseases.
Used in Drug Delivery Systems:
Similar to gallotannin, 6-AMINO-N-BETA-D-GALACTOPYRANOSYL HEXANAMIDE can also be employed in the development of novel drug delivery systems. These systems can enhance the compound's delivery, bioavailability, and therapeutic outcomes by using various organic and metallic nanoparticles as carriers. This application can potentially improve the efficacy of treatments and reduce side effects by ensuring that the compound reaches its target site more effectively.

Upstream product

• 263762-44-3 1N-(tert-butoxycarbonyl-6-aminohexanoyl)-2,3,4,6-tetra-O-acetyl-β-D-galactopyranosylamine 
• 14152-97-7 2,3,4,6-tetra-O-Acetyl-β-D-galactopyranosyl isothiocyanate 
• 6404-29-1 6-(tert-butoxycarbonylamino)hexanoic acid 

Relevant articles and documents

Synthesis and characterisation of poly (L-lactic acid) galactosyl derivatives; access to functionalised microspheres

A new series of galactosyl-derived polymers has been used for the preparation of microspheres. The strategy is based on the modification of the terminal carboxylic group L-PLA (73.000) by coupling to a galactosyl antenna in the presence of the peptide coupling agents: DCC/HOBT. The degree of functionalisation varies between 60 and 70%, and antenna density between 1.74 and 2.78. The characterisations of the new products were carried out using 1H NMR, gel permeation chromatography, and acid base titration; the size of the functionalised microspheres was determined to be 210-270 μm by DLS. (C) 2000 Elsevier Science Ltd.